Today: 13 May 2026
Fundrise VCX Stock Soars 1,300% Above NAV After Delayed NYSE Debut
24 March 2026
2 mins read

Fundrise VCX Stock Soars 1,300% Above NAV After Delayed NYSE Debut

New York, March 24, 2026, 11:08 EDT

Shares in the Fundrise Innovation Fund (VCX) changed hands at prices over 1,300% higher than net asset value Tuesday, marking just the fourth trading session since its NYSE debut. The venture fund, with investments in Anthropic, OpenAI, and SpaceX, saw trading repeatedly halted for volatility as prices ricocheted from $215.76 to $320. That’s after closing Monday at $191.81.

According to Bloomberg, demand from investors eager to tap into the fund’s private-company holdings played a key role. The episode highlights how a closed-end fund—where trading prices often disconnect from underlying asset value—can see its market price surge well above the portfolio when buyers outnumber sellers.

The surge came after a delayed debut. Fundrise originally targeted a listing date near March 10 but postponed, with the Iran war shaking investor sentiment. “Not a market that’s conducive to a wave of public offerings,” CEO Ben Miller told the Wall Street Journal last week. VCX ended up opening for trading on March 19. The Wall Street Journal

VCX, according to Fundrise, rolled out with over 100,000 investors onboard and about $650 million in net assets. As of Feb. 15, Anthropic, Databricks, OpenAI, Anduril, Ramp, and SpaceX topped the fund’s holdings—offering public investors a rare shot at privately held AI and tech firms.

This wasn’t a typical IPO—it went out as a direct listing, allowing current shareholders to trade instead of bringing in fresh capital. The distinction is key: per filings, a large group of investors who got in before Feb. 20 are locked up for six months post-listing, so just a thin sliver of shares can actually change hands. That’s been amplifying every swing.

On Tuesday, buyers were shelling out over 13 times the fund’s recent NAV of $18.97 per share, Investing.com data showed. VCX jumped 62.97% in a single session, with a five-day surge of 513.79%, according to TradingView.

Fundrise isn’t the only one going after that slice of the market. Robinhood rolled out its $658.4 million RVI fund on March 6, taking positions in Databricks, Ramp, and Revolut. CFO Shiv Verma told Reuters there’s still “a big gap in the market” when it comes to retail access to private assets. As for Destiny Tech100, this listed tech fund was trading at a lofty 21.53% premium to NAV on March 23. Pricey, but it’s nowhere near what VCX commands. Reuters

Still, premiums that reach these levels have a habit of reverting. Fundrise points out that closed-end funds often swing both above and below NAV. Its disclosure notes the private-company assets aren’t easy to trade and prices can lurch. A wave of selling, portfolio markdowns, or lockup expirations could drag VCX closer to its underlying asset value.

Miller made his case for VCX earlier this month, calling it a door to companies that are “staying private longer.” On Tuesday, investors showed they’re ready to pay a premium for that shot—at least as long as shares are scarce. Business Wire

Stock Market Today

  • Venture Global Stock Analysis: Valuation Amid Volatility
    May 12, 2026, 6:04 PM EDT. Venture Global (VG) shares have shown recent volatility, rising 1.5% in the latest session but down 15.6% over the past week. Over three months, VG gained 14.6%, with a strong year-to-date return of 65.1%. Trading at $11.62, the stock sits 55.7% below one intrinsic value estimate and 26.8% under an analyst target, suggesting a potential 5.3% undervaluation with a fair value around $12.26. The company's liquefied natural gas (LNG) business benefits from global energy shifts away from coal and Russian gas pipelines, bolstering long-term earnings forecasts. Risks include arbitration outcomes at Calcasieu Pass and project cost increases at Plaquemines and CP2 that could affect competitiveness. Investors are urged to balance these factors amid market uncertainty and evaluate additional LNG-linked opportunities.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
American Airlines Group (AAL) Stock Slips as Oil Tops $100 Again, UBS Cuts Price Target
Previous Story

American Airlines Group (AAL) Stock Slips as Oil Tops $100 Again, UBS Cuts Price Target

Microsoft Stock Falls as Bulls Call 21% Slide a Bargain, Bears Point to AI Spending Risk
Next Story

Microsoft Stock Falls as Bulls Call 21% Slide a Bargain, Bears Point to AI Spending Risk

Go toTop